Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Skin Neoplasms × Tranexamic Acid × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Pelvic Mass 1

Interventions

Nivolumab 2 Niacinamide 2 pembrolizumab 1 encorafenib 1 cemiplimab 1 binimetinib 1 avelumab 1 X-Rays 1 Vitamin A 1 Tranexamic Acid 1 Sunscreening Agents 1 Niacin 1 Itraconazole 1 Ipilimumab 1 Influenza Vaccines 1 Indocyanine Green 1 Immune Checkpoint Inhibitors 1 HhAntag691 1 Exercise 1 Dimethyl Sulfoxide 1 Biopsy 1 Ascorbic Acid 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04630886 2024-11-19

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

University of Massachusetts, Worcester

Phase EARLY_PHASE1 Terminated

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡